Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases
July 22, 2026
Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
July 2, 2021
Related Post
-
-
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
July 21, 2026
-
Ethos and North American Expand Their Indexed Universal Life Product Offering to include Children
July 21, 2026
-
IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs
July 17, 2026